Quality is a key priority in every aspect of our work. Our patients are relying on us to deliver the highest quality standards, and we are committed to living up to their expectations.
Novartis Quality Commitment signed by Vas Narasimhan, Novartis Chief Executive Officer (189 KB)

Quality assurance

We maintain a robust quality system with harmonized processes and procedures. These include providing integrated medical safety evaluations and benefit-risk assessments as well as monitoring the quality and safety of in-market and investigational products.

Novartis Quality Management System (QMS)

The Novartis Quality Management System describes how Novartis addresses external health authority regulatory requirements and other standards to ensure the highest quality in Novartis processes, products and services.

Audit program and regulatory inspections

Novartis has a robust and independent audit program that covers all Novartis internal sites and functions as well as suppliers. We regularly participate in regulatory inspections to help ensure the highest quality in our operations.

Product and patient safety training

All Novartis associates are trained to help ensure a solid understanding of our patient safety and quality processes, and we are regularly audited on our training procedures.

Product recalls

Novartis maintains a comprehensive process to assess quality defects and safety issues, and publishes product recall data over the past five years.

Third-party suppliers

Our third-party suppliers involved in product quality and patient safety processes are required to adhere to rigorous assessments, qualification requirements and monitoring.

Novartis is a global company and its policies and programs, including those described in the Report on Nonfinancial Matters, may differ depending on the jurisdiction in which it operates. Novartis is committed to complying with the law in the countries and jurisdictions in which it conducts business.